BCR-ABL-IN-7 is a WT and T315I mutant ABL kinase inhibitor.BCR-ABL-IN-7 potently inhibits WT and T315I mutant ABL kinase activity.BCR-ABL-IN-7 can be used in chronic myelogenous leukemia (CML) research.
Molecular Weight:
385.41
Purity:
98.28%
CAS Number:
[688050-42-2]
Formula:
C19H16FN3O3S
Target:
Bcr-Abl
T72958
* VAT and and shipping costs not included. Errors and price changes excepted